Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings

IEEE Transactions on Biomedical Engineering

Volumn 60, Issue 3, 2013, Pages 715-726

  Damhorst, Gregory L ^a   Watkins, Nicholas N ^a,b   Bashir, Rashid ^a  

^a University of Illinois at Urbana Champaign   (United States)

^b NABSYS INC   (United States)

Author keywords

Global health; Human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS); Micro and nanotechnology; Point of care (PoC) diagnostics

Indexed keywords

CELL COUNT; CLINICAL MANAGEMENT; CLINICAL MEASUREMENTS; GLOBAL HEALTH; HIV VIRAL LOADS; HIV/AIDS; HUMAN IMMUNODEFICIENCY VIRUS; POINT OF CARE;

DIAGNOSIS; NANOTECHNOLOGY; VIRUSES;

DISEASES;

ANTIGEN P24; GOLD NANOPARTICLE; PYROXYLIN; VIRUS CAPSID ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATOMIC FORCE MICROSCOPY; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYCLIC POTENTIOMETRY; CYTOMETRY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROTECHNOLOGY; NANOARRAY; NANOTECHNOLOGY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; POINT OF CARE TESTING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCANNING ELECTRON MICROSCOPY; VIRUS LOAD;

BIOMEDICAL ENGINEERING; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; MICROTECHNOLOGY; NANOMEDICINE; POINT-OF-CARE SYSTEMS; VIRAL LOAD; WORLD HEALTH;

EID: 84884355957     PISSN: 00189294     EISSN: 15582531     Source Type: Journal    
DOI: 10.1109/TBME.2013.2244894     Document Type: Review

References (129)

1. WHO, UNAIDS, and UNICEF, "Global HIV/AIDS Response: Epidemic update and health sector progress towards Universal Access," 2011.
2. United Nations, "The Millennium Development Goals Report 2012," 2012.
3. J. A. Aberg, J. E. Kaplan, H. Libman, P. Emmanuel, J. R. Anderson, V. E. Stone, J. M. Oleske, J. S. Currier, and J. E. Gallant, "Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the infectious diseases society of America," Clin. Infect. Dis., vol. 49, no. 5, pp. 651-681, Sep. 2009.
4. F. H. Epstein, G. Pantaleo, C. Graziosi, and A. S. Fauci, "The immunopathogenesis of human immunodeficiency virus infection," New Engl. J. Med., vol. 328, no. 5, pp. 327-335, Feb. 1993. (Pubitemid 23035333)
5. National Institute of Allergy and Infectious Diseases, "The relationship between the human immunodeficiency virus and the acquired immunodeficiency syndrome," HIV/AIDS, 2010. [Online]. Available: http://www.niaid.nih.gov/topics/hivaids/understanding/howhivcausesaids/pages/ relationshiphivaids.aspx
6. W. H. Organization, "Antiretroviral therapy for HIV infection in adults and adolescents," 2010.
7. E. M. Krantz, K. H. Hullsiek, J. F. Okulicz, A. C.Weintrob, B. K. Agan, N. F. Crum-Cianflone, A. Ganesan, T. M. Ferguson, and B. R. Hale, "Elevated CD8 counts during HAART are associated with HIV virologic treatment failure," J. Acquir. Immune Defic. Syndr., vol. 57, no. 5, pp. 396-403, Aug. 2011.
8. N. L. Michael, T. Mo, A. Merzouki, M. O. Shaughnessy, C. Oster, D. S. Burke, R. R. Redfield, and D. L. Birx, "Human immunodeficiency virus type 1 Cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort," J. Virol., vol. 69, no. 3, pp. 1868-1877, 1995.
9. K. Saksela, C. Stevens, and P. Rubinstein, "HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS," Ann. Internal Med., vol. 123, no. 9, pp. 641-648, 1995.
10. A. O. Pasternak, S. Jurriaans, M. Bakker, B. Berkhout, and V. V Lukashov, "Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia," AIDS, vol. 24, no. 11, pp. 1641-1649, Jul. 2010.
11. M. R. Furtado and L. A. Kingsley, "Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell," 1995.
12. A. O. Pasternak, S. Jurriaans, M. Bakker, J. M. Prins, B. Berkhout, and V. V Lukashov, "Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome," PLoS ONE, vol. 4, no. 12, pp. 1-10, Dec. 2009.
13. M. Zanchetta, S. Walker, N. Burighel, D. Bellanova, O. Rampon, C. Giaquinto, and A. De Rossi, "Long-term decay of the HIV-1 Reservoir in HIV-1 - infected children treated with highly active antiretroviral therapy," J. Infect. Dis., vol. 193, pp. 1718-1727, 2006. (Pubitemid 43839477)
14. A. O. Pasternak, K. W. Adema, M. Bakker, S. Jurriaans, B. Berkhout, M. Cornelissen, and V. V. Lukashov, "Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA," J. Clin. Microbiol., vol. 46, no. 7, pp. 2206-2211, Jul. 2008.
15. R. S. Soares, P. Matoso, M. Calado, and A. E. Sousa, "Strategies to quantify unspliced and multiply spliced mRNA expression in HIV-2 infection," J. Virol. Methods, vol. 175, no. 1, pp. 38-45, Jul. 2011.
16. S. H. Vermund, "Chapter 1: HIV Epidemic," in Challenges in Infectious Diseases, I. W. Fong, Ed. New York, NY, USA: Springer, 2013, pp. 3-46.
17. U.S. Food and Drug Administration, "Complete list of donor screening assays for infectious agents and HIV diagnostic assays." (2011). [Online]. Available: http://www.fda.gov/biologicsbloodvaccines/bloodbloodproducts/ approvedproducts/licensedproductsblas/blooddonorscreening/infectiousdisease/ ucm080466.htm
18. U.S. Food and Drug Administration, (2010). Vaccines, blood & biologics approved products: HIV-1 [Online]. Available: http://www.fda.gov/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/ BloodDonorScreening/InfectiousDisease/ucm126582.htm
19. T. Peterson, and M. Stuart. (2011). "PCR HIV test," Medscape Reference [Online]. Available: http://emedicine.medscape.com/article/1983649- overview
20. U.S. Food and Drug Administration and R. Klein, "Three new HIV assays approved," 2007.
21. C. Garrido, N. Zahonero, A. Corral, M. Arredondo, V. Soriano, and C. de Mendoza, "Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens Easy Q HIV-1 and Abbott RealTime HIV load tests," J. Clin. Microbiol., vol. 47, no. 4, pp. 1031-1036, Apr. 2009.
22. A. Johannessen and C. Garrido, "Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania," Clin. Infect. Dis., vol. 49, pp. 976-981, 2009.
23. S. Cassol, M. Gill, and R. Pilon, "Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper," J. Clin. Microbiol., vol. 35, pp. 2795-2801, 1997. (Pubitemid 27452412)
24. P.Mwaba, S. Cassol, A. Nunn, and R. Pilon, "Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients," Lancet, vol. 362, no. 9401, pp. 2067-2068, Dec. 2003. (Pubitemid 38032761)
25. R. de la Rica, M. M. Stevens, "Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye," Nature Nanotechnol., vol. 7, pp. 821-824, Oct. 2012.
26. C. Jennings and S. Fiscus, "Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay," J. Clin. Microbiol., vol. 43, pp. 5950-5956, 2005. (Pubitemid 43100643)
27. G. Stevens and N. Rekhviashvili, "Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype c-infected patients from South Africa," J. Clin. Microbiol., vol. 43, no. 2, pp. 857-861, Feb. 2005. (Pubitemid 40256046)
28. S. A. Fiscus, J. Wiener, E. J. Abrams, M. Bulterys, A. Cachafeiro, and R. A. Respess, "Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection," J. Clin. Microbiol., vol. 45, no. 7, pp. 2274-2277, Jul. 2007. (Pubitemid 47203806)
29. R. Respess and A. Cachafeiro, "Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings," J. Clin. Microbiol., vol. 43, pp. 506-508, 2005. (Pubitemid 40096358)
30. D. Bonard, F. Rouet, T. Toni, and A. Minga, "Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02-AG strains in Cote d'Ivoire, West Africa," J. Acquir. Immune Defic. Syndr., vol. 34, pp. 267-273, 2003. (Pubitemid 37377359)
31. K. Steegen, S. Luchters, N. De Cabooter, J. Reynaerts, K. Mandaliya, J. Plum, W. Jaoko, C. Verhofstede, and M. Temmerman, "Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings," J. Virol. Methods, vol. 146, no. 1-2, pp. 178- 187, Dec. 2007.
32. K.-B. Lee, E.-Y. Kim, C. A. Mirkin, and S. M. Wolinsky, "The use of nanoarrays for highly sensitive and selective detection of human immunodeficiency virus type 1 in plasma," Nano Lett., vol. 4, no. 10, pp. 1869-1872, Oct. 2004.
33. Z. A. Parpia, R. Elghanian, A. Nabatiyan, D. R. Hardie, and D. M. Kelso, "p24 antigen rapid test for diagnosis of acute pediatric HIV infection," J. Acquir. Immune Defic. Syndr., vol. 55, no. 4, pp. 413-419, Dec. 2010.
34. S. Tang, J. Zhao, and J. Storhoff, "Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen," J. Acquir. Immune Defic. Syndr., vol. 46, no. 2, pp. 231-237, Oct. 2007. (Pubitemid 47482620)
35. S. Tang and I. Hewlett, "Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen," J. Infect. Dis., vol. 201, no. Suppl. 1, pp. S59-S64, Apr. 2010.
36. E. Kim, J. Stanton, and B. Korber, "Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method," Nanomedicine, vol. 3, no. 3, pp. 293-303, 2008. (Pubitemid 351827307)
37. J. Nam, C. Thaxton, and C. Mirkin, "Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins," Science, vol. 301, no. 5641, pp. 1884-1886, Sep. 2003. (Pubitemid 37221389)
38. D. H. Ekstrand, R. J. Awad, C. F. Källander, and J. S. Gronowitz, "A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive-product detection, with special reference to human-immunodeficiency-virus isolation," Biotechnol. Appl. Biochem., vol. 23 (Pt 2), pp. 95-105, Apr. 1996.
39. A. Malmsten, X.-W. Shao, K. Aperia, G. E. Corrigan, E. Sandström, C. F. R. Källander, T. Leitner, and J. S. Gronowitz, "HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma," J. Med. Virol., vol. 71, no. 3, pp. 347-359, Nov. 2003. (Pubitemid 37176623)
40. A. Malmsten, X.-W. Shao, S. Sjödahl, E.-L. Fredriksson, I. Pettersson, T. Leitner, C. F. R. Källander, E. Sandström, and J. S. Gronowitz, "Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma," J. Med. Virol., vol. 76, no. 3, pp. 291-296, Jul. 2005. (Pubitemid 40770882)
41. J. Lombart, M. Vray, and A. Kafando, "Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa," Aids, vol. 19, pp. 1273-1277, 2005. (Pubitemid 41224896)
42. M. Mine, K. Bedi, T. Maruta, D. Madziva, M. Tau, T. Zana, T. Gaolathe, S. Moyo, K. Seipone, N. Ndwapi, M. Essex, and R. Marlink, "Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: A decentralization pilot study," J. Virol. Methods, vol. 159, no. 1, pp. 93-97, Jul. 2009.
43. V. Greengrass, B. Lohman, L. Morris, M. Plate, P. M. Steele, J. L. Walson, and S. M. Crowe, "Assessment of the low-cost cavidi exavir load assay for monitoring HIV viral load in pediatric and adult patients," J. Acquir. Immune Defic. Syndr., vol. 52, no. 3, pp. 387-390, Nov. 2009.
44. J. Braun, J.-C. Plantier, M.-F. Hellot, E. Tuaillon, M. Gueudin, F. Damond, A. Malmsten, G. E. Corrigan, and F. Simon, "A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes," AIDS, vol. 17, no. 3, pp. 331-336, Feb. 2003. (Pubitemid 36223257)
45. S. Sivapalasingam and S. Essajee, "Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: Implications for resource-limited settings," J. Clin. Microbiol., vol. 43, pp. 3793-3796, 2005. (Pubitemid 41129662)
46. H. S. Iqbal, P. Balakrishnan, A. J. Cecelia, S. Solomon, N. Kumarasamy, V. Madhavan, K. G. Murugavel, A. K. Ganesh, S. S. Solomon, K. H. Mayer, and S. M. Crowe, "Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings," J. Med. Microbiol., vol. 56, no. 12, pp. 1611-1614, Dec. 2007. (Pubitemid 350276510)
47. V. L. Greengrass, M. M. Plate, P. M. Steele, J. T. Denholm, C. L. Cherry, L. M. Morris, A. Hearps, and S. M. Crowe, "Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring," J. Clin. Microbiol., vol. 47, no. 9, pp. 3011-3013, Sep. 2009.
48. W. Labbett, A. Garcia-Diaz, Z. Fox, G. S. Clewley, T. Fernandez, M. Johnson, and A. M. Geretti, "Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load," J. Clin. Microbiol., vol. 47, no. 10, pp. 3266-3270, Oct. 2009.
49. P. Stewart, A. Cachafeiro, S. Napravnik, J. J. Eron, I. Frank, C. van der Horst, R. J. Bosch, D. Bettendorf, P. Bohlin, and S. A. Fiscus, "Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay," J. Clin. Virol., vol. 49, no. 3, pp. 198-204, Nov. 2010.
50. W. Tang, W. H. A. Chow, Y. Li, H. Kong, Y.-W. Tang, and B. Lemieux, "Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings," J. Infect. Dis., vol. 201, no. Suppl 1, pp. S46-S51, Apr. 2010.
51. H. H. Lee, M. A. Dineva, Y. L. Chua, A. V Ritchie, I. Ushiro-Lumb, and C. A. Wisniewski, "Simple amplification-based assay: A nucleic acid-based point-of-care platform for HIV-1 testing," J. Infect. Dis., vol. 201, no. Suppl 1, pp. S65-S72, Apr. 2010.
52. S. H. Lee, S.-W. Kim, J. Y. Kang, and C. H. Ahn, "A polymer lab-on-a-chip for reverse transcription (RT)-PCR based point-of-care clinical diagnostics," Lab Chip, vol. 8, no. 12, pp. 2121-2127, Dec. 2008.
53. F. Shen, B. Sun, J. E. Kreutz, E. K. Davydova, W. Du, P. L. Reddy, L. J. Joseph, and R. F. Ismagilov, "Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load," J. Amer. Chemical Soc., vol. 133, no. 44, pp. 17705-17712, Nov. 2011.
54. B. A. Rohrman, V. Leautaud, E. Molyneux, and R. R. Richards-Kortum, "A Lateral Flow assay for quantitative detection of amplified HIV-1 RNA," PLoS ONE, vol. 7, no. 9, pp. 1-8, Sep. 2012.
55. S. Tanriverdi, L. Chen, and S. Chen, "A rapid and automated sample-to-result HIV load test for near-patient application," J. Infect. Dis., vol. 201, no. Suppl 1, pp. S52-S58, Apr. 2010.
56. Y.-G. Kim, S. Moon, D. R. Kuritzkes, and U. Demirci, "Quantum dot-based HIV capture and imaging in a microfluidic channel," Biosens. Bioelectron., vol. 25, no. 1, pp. 253-258, Sep. 2009.
57. S. Wang, A. Ip, F. Xu, F. F. Giguel, S. Moon, A. Akay, D. R. Kuritzkes, and U. Demirci, "Development of a microfluidic system for measuring HIV-1 viral load," Defense, vol. 7666, pp. 76661H-1-76661H-6, 2010.
58. S. Wang, M. Esfahani, U. A. Gurkan, F. Inci, D. R. Kuritzkes, and U. Demirci, "Efficient on-chip isolation of HIV subtypes," Lab Chip, vol. 12, pp. 1508-1515, Mar. 2012.
59. G. Chen, C. J. Alberts, W. Rodriguez, and M. Toner, "Concentration and purification of human immunodeficiency virus type 1 virions by microfluidic separation of superparamagnetic nanoparticles," Anal. Chem., vol. 82, no. 2, pp. 723-728, Jan. 2010.
60. S. Cassol, A. Butcher, and S. Kinard, "Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1," J. Clin. Microbiol., vol. 32, pp. 2641-2645, 1994. (Pubitemid 24319095)
61. J.Weidner, U. Cassens, W. Göhde, W. Sibrowski, G. Odaibo, D. Olaleye, D. Reichelt, and B. Greve, "An improved PCR method for detection of HIV-1 proviral DNA of a wide range of subtypes and recombinant forms circulating globally," J. Virol. Methods, vol. 172, no. 1-2, pp. 22-26, Mar. 2011.
62. T. E. Schutzbank and J. Smith, "Detection of human immunodeficiency virus type 1 proviral DNA by PCR using an electrochemiluminescencetagged probe," J. Clin. Microbiol., vol. 33, no. 8, pp. 2036-2041, Aug. 1995.
63. D. Zella, A. Cavicchini, and E. Cattaneo, "Utilization of a DNA enzyme immunoassay for the detection of proviral DNA of human immunodeficiency virus type 1 by polymerase chain reaction," Clin. Diagn. Virol., vol. 3, no. 2, pp. 155-164, Feb. 1995.
64. K. L. Barlow, J. H. C. Tosswill, J. V Parry, and J. P. Clewley, "Performance of the amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with false-negative results," J. Clin. Microbiol., vol. 35, no. 11, pp. 2846-2853, 1997.
65. J. W. Bremer, J. F. Lew, E. Cooper, G. V Hillyer, J. Pitt, E. Handelsman, D. Brambilla, J. Moye, and R. Haft, "Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants. Transmission study," J. Pediatr., vol. 129, pp. 198-207, 1996. (Pubitemid 27483790)
66. C. Delamare, M. Burgard, and M. Mayaux, "HIV-1 RNA detection in plasma for the diagnosis of infection in neonates," J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., vol. 15, no. 2, pp. 121-125, 1997. (Pubitemid 27328039)
67. CDC, "HIV Testing Basics for Consumers," (2010). [Online]. Available: http://www.cdc.gov/hiv/topics/testing/resources/qa/index.htm
68. C. Christopherson, Y. Kidane, B. Conway, H. Sheppard, S. Kwok, and J. Krowka, "PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells these include : PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells," J. Clin. Microbiol., vol. 38, pp. 630-634, 2000.
69. N. Désiré, A. Dehée, V. Schneider, C. Jacomet, C. Goujon, P. Girard, W. Rozenbaum, and J. Nicolas, "Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay," J. Clin. Microbiol., vol. 39, pp. 1303-1310, 2001. (Pubitemid 32275425)
70. L. G. Kostrikis, G. Touloumi, R. Karanicolas, N. Pantazis, C. Anastassopoulou, J. J. Goedert, A. Hatzakis, and A. Karafoulidou, "Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load," J. Virol., vol. 76, pp. 10099-10108, 2002.
71. A. E. Hatzakis, G. Touloumi, N. Pantazis, C. G. Anastassopoulou, O. Katsarou, A. Karafoulidou, J. J. Goedert, and L. G. Kostrikis, "Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy," AIDS, vol. 18, pp. 2261-2267, 2004. (Pubitemid 39620218)
72. D. Gibellini, M. Borderi, E. De Crignis, R. Cicola, L. Cimatti, F. Vitone, F. Chiodo, and M. C. Re, "HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals," J. Infect., vol. 56, no. 3, pp. 219-225, Mar. 2008.
73. M. C. Re, F. Vitone, C. Biagetti, P. Schiavone, F. Alessandrini, I. Bon, E. de Crignis, and D. Gibellini, "HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients," Clin. Microbiol. Infect., vol. 16, no. 6, pp. 640-646, Jun. 2010.
74. S. M. Moroney, L. C. Heller, and R. H. Widen, "Evaluation of two TaqMan PCR assays for the detection of HIV-1 proviral DNA in blood samples," J. Microbiol. Methods, vol. 65, no. 2, pp. 350-353, May 2006.
75. M. S. Malnati, G. Scarlatti, F. Gatto, F. Salvatori, G. Cassina, T. Rutigliano, R. Volpi, and P. Lusso, "A universal real-time PCR assay for the quantification of group-MHIV-1 proviral load," Nature Protocols, vol. 3, no. 7, pp. 1240-1248, Jul. 2008.
76. A. De Rossi, M. Zanchetta, F. Vitone, G. Antonelli, P. Bagnarelli, L. Buonaguro, M. R. Capobianchi, M. Clementi, I. Abbate, F. Canducci, A. Monachetti, E. Riva, G. Rozera, C. Scagnolari, M. Tagliamonte, M. Carla, and I. Society, "Quantitative HIV-1 proviral DNA detection: A multicentre analysis," New Microbiol., vol. 33, pp. 293-302, 2010.
77. S. R. Jangam, D. H. Yamada, S. M. McFall, and D. M. Kelso, "Rapid, point-of-care extraction of human immunodeficiency virus type 1 proviral DNA from whole blood for detection by real-time PCR," J. Clin. Microbiol., vol. 47, no. 8, pp. 2363-2368, Aug. 2009.
78. S. R. Jangam, A. K. Agarwal, K. Sur, and D. M. Kelso, "A point-of-care PCR test for HIV-1 detection in resource-limited settings," Biosens. Bioelectron., pp. 69-75, Oct. 2012.
79. J.-H. Wang, L. Cheng, C.-H. Wang, W.-S. Ling, S.-W. Wang, and G.-B. Lee, "An integrated chip capable of performing sample pretreatment and nucleic acid amplification for HIV-1 detection," Biosens. Bioelectron., vol. 41, pp. 484-491, 2013.
80. S. Y. Bae, H. C. Park, J. S. Oh, S.-Y. Yoon, D. W. Park, I. K. Choi, H. J. Kim, J. H. Oh, D. S. Hur, C. Chung, J. K. Chang, J. P. Robinson, and C. S. Lim, "Absolute CD4 cell count using a plastic microchip and a microscopic cell counter," Cytometry, vol. 76B, no. 5, pp. 345-353, Sep. 2009.
81. W. R. Rodriguez, N. Christodoulides, P. N. Floriano, S. Graham, S. Mohanty, M. Dixon, M. Hsiang, T. Peter, S. Zavahir, I. Thior, D. Romanovicz, B. Bernard, A. P. Goodey, B. D. Walker, and J. T. McDevitt, "A microchip CD4 counting method for HIV monitoring in resource-poor settings," PLoS Med., vol. 2, no. 7, pp. 663-672, Jul. 2005.
82. M. A. Alyassin, S. Moon, H. O. Keles, F. Manzur, R. L. Lin, E. Hæggstrom, D. R. Kuritzkes, and U. Demirci, "Rapid automated cell quantification on HIV microfluidic devices," Lab Chip, vol. 9, no. 23, pp. 3364-3369, Dec. 2009.
83. S. Thorslund, R. Larsson, F. Nikolajeff, J. Bergquist, and J. Sanchez, "Bioactivated PDMS microchannel evaluated as sensor for human CD4+ cells - The concept of a point-of-care method for HIV monitoring," Sens. Actuators B, Chem., vol. 123, no. 2, pp. 847-855, May 2007. (Pubitemid 46678775)
84. S. Thorslund, R. Larsson, J. Bergquist, F. Nikolajeff, and J. Sanchez, "A PDMS-based disposable microfluidic sensor for CD4+ lymphocyte counting," Biomed. Microdevices, vol. 10, no. 6, pp. 851-857, Dec. 2008.
85. J. V Jokerst, P. N. Floriano, N. Christodoulides, G. W. Simmons, and J. T. McDevitt, "Integration of semiconductor quantum dots into nano-bio-chip systems for enumeration of CD4+ T cell counts at the point-of-need," Lab Chip, vol. 8, no. 12, pp. 2079-2090, Dec. 2008.
86. J. V Jokerst, J. W. Jacobson, B. D. Bhagwandin, P. N. Floriano, N. Christodoulides, and J. T. McDevitt, "Programmable nano-bio-chip sensors: Analytical meets clinical," Anal. Chem., vol. 82, no. 5, pp. 1571-1579, Mar. 2010.
87. X. Li, A. Ymeti, B. Lunter, C. Breukers, A. G. J. Tibbe, L. W. M. M. Terstappen, and J. Greve, "CD4+ T lymphocytes enumeration by an easy-to-use single platform image cytometer for HIV monitoring in resource-constrained settings," Cytometry, vol. 72B, no. 5, pp. 397-407, Sep. 2007. (Pubitemid 350194357)
88. A. Ymeti, X. Li, B. Lunter, and C. Breukers, "A single platform image cytometer for resource-poor settings to monitor disease progression in HIV infection," Cytometry, vol. 71 A, no. 3, pp. 132-142, Mar. 2007.
89. X. Li, A. G. J. Tibbe, E. Droog, L. W. M. M. Terstappen, and J. Greve, "An immunomagnetic single-platform image cytometer for cell enumeration based on antibody specificity," Clin. Vaccine Immunol., vol. 14, no. 4, pp. 412-419, Apr. 2007. (Pubitemid 46732552)
90. X. Cheng, D. Irimia, M. Dixon, K. Sekine, U. Demirci, L. Zamir, R. G. Tompkins, W. Rodriguez, and M. Toner, "A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects," Lab Chip, vol. 7, no. 2, pp. 170-178, Feb. 2007. (Pubitemid 46238539)
91. X. Cheng, D. Irimia, M. Dixon, J. C. Ziperstein, U. Demirci, L. Zamir, R. G. Tompkins, M. Toner, and W. R. Rodriguez, "A microchip approach for practical label-free CD4+ T-cell counting of HIV-infected subjects in resource-poor settings," J. Acquir. Immune Defic. Syndr., vol. 45, no. 3, pp. 257-261, 2007. (Pubitemid 47012370)
92. X. Cheng, A. Gupta, C. Chen, R. G. Tompkins, W. Rodriguez, and M. Toner, "Enhancing the performance of a point-of-care CD4+ T-cell counting microchip through monocyte depletion for HIV/AIDS diagnostics," Lab Chip, vol. 9, no. 10, pp. 1357-1364, May 2009.
93. M. Beck, S. Brockhuis, N. van der Velde, C. Breukers, J. Greve, and L. W. M. M. Terstappen, "On-chip sample preparation by controlled release of antibodies for simple CD4 counting," Lab Chip, vol. 12, no. 1, pp. 167-173, Jan. 2012.
94. C. D. Chin, V. Linder, and S. K. Sia, "Commercialization of microfluidic point-of-care diagnostic devices," Lab Chip, vol. 12, no. 12, pp. 2118-2134, Jun. 2012.
95. S. Mtapuri-Zinyowera, M. Chideme, D. Mangwanya, O. Mugurungi, S. Gudukeya, K. Hatzold, A. Mangwiro, G. Bhattacharya, J. Lehe, and T. Peter, "Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe," J. Acquir. Immune Defic. Syndr., vol. 55, no. 1, pp. 1-7, Sep. 2010.
96. I. V Jani, N. E. Sitoe, P. L. Chongo, E. R. Alfai, J. I. Quevedo, O. Tobaiwa, J. D. Lehe, and T. F. Peter, "Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing," AIDS, vol. 25, no. 6, pp. 807-812, Mar. 2011.
97. B. Larson, K. Schnippel, B. Ndibongo, L. Long, M. P. Fox, and S. Rosen, "How to estimate the cost of point-of-care CD4 testing in program settings: An example using the Alere Pima analyzer in South Africa," PLoS ONE, vol. 7, no. 4, pp. 1-8, Apr. 2012.
98. Y. C. Manabe, Y. Wang, A. Elbireer, B. Auerbach, and B. Castelnuovo, "Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy," PLoS ONE, vol. 7, no. 4, pp. 1-5, Apr. 2012.
99. S. Herbert, S. Edwards, G. Carrick, A. Copas, C. Sandford, M. Amphlett, and P. Benn, "Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service," Sexually Transmitted Infect., vol. 88, no. 6, pp. 413-417, Oct. 2012.
100. I. Jani, N. Sitoe, J. Quevedo, J. Lehe, and T. Peter, "Cost comparison of point-of-care and laboratory CD4 testing in resource-limited settings," presented at 6th IAS Conf. HIV Pathogenesis, Treatment Prevention, Rome, Italy, 2011.
101. J. T. Gohring and X. Fan, "Label free detection of CD4+ and CD8+ T cells using the optofluidic ring resonator," Sensors, vol. 10, no. 6, pp. 5798-5808, Jun. 2010.
102. S. Moon, H. O. Keles, A. Ozcan, A. Khademhosseini, E. Haeggstrom, D. Kuritzkes, and U. Demirci, "Integrating microfluidics and lensless imaging for point-of-care testing," Biosens. Bioelectron., vol. 24, no. 11, pp. 3208-3214, Jul. 2009.
103. A. Ozcan and U. Demirci, "Ultra wide-field lens-free monitoring of cells on-chip," Lab Chip, vol. 8, no. 1, pp. 98-106, Jan. 2008. (Pubitemid 350294131)
104. Z. Wang, S. Chin, C. Chin, and J. Sarik, "Microfluidic CD4+ Tcell counting device using chemiluminescence-based detection," Anal. Chem., vol. 82, no. 1, pp. 36-40, Jan. 2010.
105. S. Moon, U. A. Gurkan, J. Blander, W. W. Fawzi, S. Aboud, F. Mugusi, D. R. Kuritzkes, and U. Demirci, "Enumeration of CD4+ T-cells using a portable microchip count platform in Tanzanian HIV-infected patients," PLoS ONE, vol. 6, no. 7, pp. 1-8, Jul. 2011.
106. N. N. Mishra, S. Retterer, T. J. Zieziulewicz, M. Isaacson, D. Szarowski, D. E. Mousseau, D. A. Lawrence, and J. N. Turner, "On-chip microbiosensor for the detection of human CD4+ cells based on AC impedance and optical analysis," Biosens. Bioelectron., vol. 21, no. 5, pp. 696-704, Nov. 2005. (Pubitemid 41476301)
107. N. Mishra and S. Retterer, "Bio-impedance sensing device (BISD) for detection of human CD4+ cells," in Proc. NSTI Nanotechnol. Conf. Trade Show, 2004, pp. 228-231.
108. X. Jiang and M. G. Spencer, "Electrochemical impedance biosensor with electrode pixels for precise counting of CD4+ cells: A microchip for quantitative diagnosis of HIV infection status of AIDS patients," Biosens. Bioelectron., vol. 25, no. 7, pp. 1622-1628, Mar. 2010.
109. X. Cheng, Y. Liu, D. Irimia, U. Demirci, L. Yang, L. Zamir, W. R. Rodríguez, M. Toner, and R. Bashir, "Cell detection and counting through cell lysate impedance spectroscopy in microfluidic devices," Lab Chip, vol. 7, no. 6, pp. 746-755, Jun. 2007. (Pubitemid 46848700)
110. P. Kiesel, M. Beck, and N. Johnson, "Monitoring CD4 in whole blood with an opto-fluidic detector based on spatially modulated fluorescence emission," Cytometry, vol. 79A, no. 4, pp. 317-324, Apr. 2011.
111. J.-H. Wang, C.-H. Wang, C.-C. Lin, H.-Y. Lei, and G.-B. Lee, "An integrated microfluidic system for counting of CD4+ /CD8+ T lymphocytes," in Microfluidics and Nanofluidics. vol. 10, New York, NY, USA: Springer, Mar. 2011, pp. 531-541.
112. H. Yun, H. Bang, J. Min, C. Chung, J. K. Chang, and D.-C. Han, "Simultaneous counting of two subsets of leukocytes using fluorescent silica nanoparticles in a sheathless microchip flow cytometer," Lab Chip, vol. 10, no. 23, pp. 3243-3254, Dec. 2010.
113. X. Mao, S.-C. S. Lin, C. Dong, and T. J. Huang, "Single-layer planar on-chip flow cytometer using microfluidic drifting based three-dimensional (3D) hydrodynamic focusing," Lab Chip, vol. 9, no. 11, pp. 1583-1589, Jun. 2009.
114. Y.-N. Wang, Y. Kang, D. Xu, C. H. Chon, L. Barnett, S. A. Kalams, D. Li, and D. Li, "On-chip counting the number and the percentage of CD4+ T lymphocytes," Lab Chip, vol. 8, no. 2, pp. 309-315, Feb. 2008. (Pubitemid 351191411)
115. X. Wu, Y. Kang, Y.-N. Wang, D. Xu, D. Li, and D. Li, "Microfluidic differential resistive pulse sensors," Electrophoresis, vol. 29, no. 13, pp. 2754-2759, Jul. 2008. (Pubitemid 352006109)
116. X. Wu, C. H. Chon, Y.-N. Wang, Y. Kang, and D. Li, "Simultaneous particle counting and detecting on a chip," Lab Chip, vol. 8, no. 11, pp. 1943-1949, Nov. 2008.
117. D. Holmes, D. Pettigrew, C. H. Reccius, J. D. Gwyer, C. van Berkel, J. Holloway, D. E. Davies, and H. Morgan, "Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry," Lab Chip, vol. 9, no. 20, pp. 2881-2889, Oct. 2009.
118. C. van Berkel, J. D. Gwyer, S. Deane, N. G. Green, N. Green, J. Holloway, V. Hollis, and H. Morgan, "Integrated systems for rapid point of care (PoC) blood cell analysis," Lab Chip, vol. 11, no. 7, pp. 1249-1255, Apr. 2011.
119. D. Holmes and H. Morgan, "Single cell impedance cytometry for identification and counting of CD4 T-cells in human blood using impedance labels," Anal. Chem., vol. 82, no. 4, pp. 1455-1461, Feb. 2010.
120. N. Watkins, B. M. Venkatesan, M. Toner, W. Rodriguez, and R. Bashir, "A robust electrical microcytometer with 3-dimensional hydrofocusing," Lab Chip, vol. 9, no. 22, pp. 3177-3184, Nov. 2009.
121. N. N. Watkins, S. Sridhar, X. Cheng, G. Chen, M. Toner, W. Rodriguez, and R. Bashir, "A microfabricated electrical differential counter for the selective enumeration of CD4+ T lymphocytes," Lab Chip, vol. 11, no. 8, pp. 1437-1447, Apr. 2011.
122. H. Zhu, J. Yan, and A. Revzin, "Catch and release cell sorting: Electrochemical desorption of T-cells from antibody-modified microelectrodes," Colloids Surf. B Biointerfaces, vol. 64, no. 2, pp. 260-268, Jul. 2008.
123. J. Robertus, W. R. Browne, and B. L. Feringa, "Dynamic control over cell adhesive properties using molecular-based surface engineering strategies," Chemical Soc. Rev., vol. 39, no. 1, pp. 354-378, Jan. 2010.
124. U. A. Gurkan, T. Anand, H. Tas, D. Elkan, A. Akay, H. O. Keles, and U. Demirci, "Controlled viable release of selectively captured label-free cells in microchannels," Lab Chip, vol. 11, no. 23, pp. 3979-3989, Dec. 2011.
125. C.Willyard, "Simpler tests for immune cells could transform AIDS care in Africa," Nature Med., vol. 13, no. 10, p. 1131, Oct. 2007.
126. D. S. Boyle, K. R. Hawkins, M. S. Steele, M. Singhal, and X. Cheng, "Emerging technologies for point-of-care CD4 T-lymphocyte counting," Trends Biotechnol., vol. 30, no. 1, pp. 45-54, Jan. 2012.
127. R. Zachariah, S. D. Reid, P. Chaillet, M. Massaquoi, E. J. Schouten, and A. D. Harries, "Viewpoint:Why do we need a point-of-care CD4 test for low-income countries?," Tropical Med. Int. Health : TM & IH, vol. 16, no. 1, pp. 37-41, Jan. 2011.
128. UNAIDS "UNAIDS World AIDS Day Report," 2012.
129. T. Quinn and M. Wawer, "Viral load and heterosexual transmission of human immunodeficiency virus type 1," New Engl. J. Med., vol. 342, no. 13, pp. 921-929, Mar. 2000. (Pubitemid 30177052)